Linjun Weng
Impact in
-
- Phagocytosis and Immune Regulation
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- interferon and immune responses
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Ubiquitin and proteasome pathways 2
- PI3K/AKT/mTOR signaling in cancer 1
-
- Phagocytosis and Immune Regulation 2
- Immunotherapy and Immune Responses 2
- interferon and immune responses 1
- Co-authors
- Lan Fang (3 shared papers)Qi Wu (2 shared papers)Pengcheng Zhao (2 shared papers)Yue Liu (2 shared papers)Yanjin Wang (2 shared papers)Jin Zhang (2 shared papers)Yufeng Shi (2 shared papers)Yanrong Yang (2 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (1 paper)Briefings in Bioinformatics (1 paper)Advanced Science (1 paper)Cell Death and Differentiation (1 paper)Journal of Advanced Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Linjun Weng
4 papers receiving 277 citations
Linjun Weng's Hit Papers
Peers
Comparison fields: 5 of 51
- Immunology 172
- Oncology 82
- Cancer Research 33
- Molecular Biology 113
- Genetics 12
Countries citing papers authored by Linjun Weng
This map shows the geographic impact of Linjun Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linjun Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linjun Weng more than expected).
Fields of papers citing papers by Linjun Weng
This network shows the impact of papers produced by Linjun Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linjun Weng. The network helps show where Linjun Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Linjun Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Emerging phagocytosis checkpoints in cancer immunotherapy Hit paper breakdown → | 2023 | 166 |
| 2 | 2020 | 70 | |
| 3 | 2023 | 37 | |
| 4 | 2024 | 11 | |
| 5 | 2021 | 0 |
About Linjun Weng
Linjun Weng is a scholar working on Molecular Biology, Immunology, Physiology, Oncology and Epidemiology, having authored 5 papers that have together received 284 indexed citations. Recurring topics across this work include Phagocytosis and Immune Regulation (2 papers), Ubiquitin and proteasome pathways (2 papers), Erythrocyte Function and Pathophysiology (2 papers), Immunotherapy and Immune Responses (2 papers), interferon and immune responses (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Cancer-related Molecular Pathways (1 paper) and PI3K/AKT/mTOR signaling in cancer (1 paper). The work is most often cited by research in Immunology (172 citations), Oncology (82 citations), Cancer Research (33 citations), Molecular Biology (113 citations) and Genetics (12 citations). Linjun Weng has collaborated with scholars based in China and United States. Frequent co-authors include Lan Fang, Qi Wu, Pengcheng Zhao, Yue Liu, Yanjin Wang, Jin Zhang, Yufeng Shi, Yanrong Yang, Ping Wang and Hongling Tian. Their work appears in journals such as Signal Transduction and Targeted Therapy, Briefings in Bioinformatics, Advanced Science, Cell Death and Differentiation and Journal of Advanced Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.